Related Experiment Video
Updated: Apr 29, 2026
09:44
Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
10.7K
The brain in acute on chronic liver failure
Gavin Wright1, Yalda Sharifi, Maria Jover-Cobos
1Institute for Liver and Digestive Health, Liver Failure Group, UCL Institute of Hepatology, The Royal Free Hospital, Upper Third UCL Medical School, Pond Street, London, NW3 2PF, UK, gavin.wright@btuh.nhs.uk.
Metabolic Brain Disease
|May 20, 2014
Summary
Acute-on-chronic liver failure (ACLF) can cause severe brain issues, including high intracranial pressure and cerebral edema. More research is needed to develop targeted therapies for these critical neurological complications.
Area of Science:
- Hepatology
- Neurology
- Critical Care Medicine
Background:
- Acute-on-chronic liver failure (ACLF) is a severe clinical condition with high mortality, characterized by acute liver injury superimposed on cirrhosis.
- ACLF can lead to multiorgan dysfunction, including severe neurological complications like intracranial hypertension and cerebral edema, mimicking acute liver failure.
- Current understanding of ACLF's cerebral sequelae is based on limited clinical observation, despite recent advancements in definitions and animal models.
Purpose of the Study:
- To review and synthesize existing clinical and experimental data on the neurological manifestations of ACLF.
- To characterize the brain events occurring in ACLF patients.
- To inform the development of targeted therapeutic interventions for ACLF-associated neurological complications.
Main Methods:
- Review of current clinical and experimental literature on ACLF.
- Analysis of data characterizing brain events in ACLF.
- Synthesis of findings to identify therapeutic targets.
Main Results:
- ACLF presents with significant neurological complications, including intracranial hypertension and cerebral edema, in a subset of patients.
- Existing interventions for ACLF often target cirrhosis or acute liver injury independently, not the specific neurological sequelae.
- There is a critical need for interventional studies focusing on ACLF's neurological impact.
Conclusions:
- ACLF poses a significant threat due to its potential for severe neurological complications.
- Targeted therapies are needed to address the specific brain manifestations of ACLF.
- Further research and interventional studies are essential for improving outcomes in ACLF patients with neurological involvement.
Related Concept Videos
01:29Hepatic Encephalopathy
46
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
46
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
01:26Brain Abscess l: Introduction
20
A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial...
20
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
382
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
382
01:24Cirrhosis II: Pathophysiology
41
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
41
01:28Traumatic Brain Injury l: Introduction
20
DefinitionTraumatic brain injury, or TBI, is a disturbance of normal brain function induced by an external mechanical force, such as a direct blow to the head or a penetrating injury. It can affect both brain structure and function, producing a wide range of clinical outcomes. TBI is a heterogeneous condition, meaning its effects may differ based on the type, location, and severity of the injury.Basis of ClassificationTBI is classified based on severity, injury mechanism, or pathophysiology. In...
20